Late filing
elevated
Filing comparison
Lomond Therapeutics Holdings, Inc. told the SEC it could not file its annual report on time
Does not expect a significant change in results. Filed on the statutory due date.
(the “Company”) is filing this Notification of Late Filing on Form 12b-25 with respect to its Annual Report on Form 10-K as of and for the year ended December 31, 2025 (the “Form 10-K”). The Company has determined that it is unable to file its Form 10-K within the prescribed time period without unreasonable effort or expense. The Company requires additional time to finalize, and to allow its auditors to complete the audit of, its consolidated financial statements and other information in its Form 10-K.
Evidence
- Anticipates significant change
- No
- Days past due date
- 0
- Routine
- No
- Severity
- elevated
- Source
- Form 12b-25 (notification of late filing)
- Stated reason
- (the “Company”) is filing this Notification of Late Filing on Form 12b-25 with respect to its Annual Report on Form 10-K as of and for the year ended December 31, 2025 (the “Form 10-K”). The Company has determined that it is unable to file its Form 10-K within the prescribed time period without unreasonable effort or expense. The Company requires additional time to finalize, and to allow its auditors to complete the audit of, its consolidated financial statements and other information in its Form 10-K.
- Why
- The company told the SEC it could not file a periodic report on time, using Form 12b-25.